Impact of cardiac and autonomic nervous system alterations in cirrhosis patients.
Not Applicable
- Conditions
- Health Condition 1: K74- Fibrosis and cirrhosis of liver
- Registration Number
- CTRI/2021/12/038676
- Lead Sponsor
- Post Graduate Institute of Medical Education and Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Age above 18 years.
2.Patients having confirmed diagnosis of decompensated cirrhosis, any etiology (CTP class B and C will be included)
3.Patients have given informed and written consent for participation in the study.
Exclusion Criteria
1.Pre-existing or known chronic kidney disease (CKD), cardiovascular accident, coronary artery disease, chronic obstructive pulmonary disease
2.Diagnosis of hepatocellular carcinoma or other malignancy.
3.Acute on chronic liver failure (ACLF), AKI, Refractory Ascites
4.Active infection
5.Active bleeding within last 7 days
6.Human immunodeficiency virus seropositivity
7.Pregnancy and lactation
8.Refusal to participate in study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome measures <br/ ><br>1. Overall survival <br/ ><br>Timepoint: 1 year <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1. Development of acute kidney injury during 1 year.Timepoint: 3m, 6m, 9m, 12m.;2. Development of refractory ascites during 1 year.Timepoint: 3m, 6m, 9m, 12m.